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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the etiological agent of COVID-19, is considered a zoonotic path-
ogen mainly transmitted human to human. Few reports indicate
that pets may be exposed to the virus. The present report de-
scribes a cat suffering from severe respiratory distress and throm-
bocytopenia living with a family with several members affected by
COVID-19. Clinical signs of the cat prompted humanitarian eutha-
nasia and a detailed postmortem investigation to assess whether a
COVID-19−like disease was causing the condition. Necropsy results
showed the animal suffered from feline hypertrophic cardiomyop-
athy and severe pulmonary edema and thrombosis. SARS-CoV-2
RNA was only detected in nasal swab, nasal turbinates, and mes-
enteric lymph node, but no evidence of histopathological lesions
compatible with a viral infection were detected. The cat serocon-
verted against SARS-CoV-2, further evidencing a productive infec-
tion in this animal. We conclude that the animal had a subclinical
SARS-CoV-2 infection concomitant to an unrelated cardiomyopa-
thy that led to euthanasia.
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The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) is the etiological agent of COVID-19, de-
clared as pandemic on March 11, 2020. Since its initial report at
the end of 2019, the World Health Organization has reported
more than 17.3 million human cases of COVID-19 causing over
674,000 deaths (accessed on August 1, 2020, https://covid19.who.
int/). SARS-CoV-2 is believed to have originated in bats (1).
However, the species barrier jump from bats to humans is con-
sidered unlikely, and the most probable hypothesis includes the
existence of an intermediate host (2). Such a scenario points out
the importance of animals in the emergence of COVID-19 in
China, which further emphasizes the need of a One Health ap-
proach to tackle emerging diseases.
The role of animals in the context of COVID-19 is not only
circumscribed to its origin and spillover events, but also at other
key levels. First is the need to develop animal infection models
for SARS-CoV-2 to accelerate the preclinical phase for devel-
oping vaccines and antiviral drugs against this novel agent.
Several models for SARS-CoV-2 infection have been so far de-
veloped in animals, including Egyptian fruit bat, ferret, golden
Syrian hamster, cat, humanized angiotensin-converting enzyme 2
(ACE2) transgenic mice (hACE2 mice), and some nonhuman
primate species (3–8). Second, livestock and zoo animals as well
as pets can be exposed to SARS-CoV-2 by contacts with
COVID-19 patients or SARS-CoV-2 subclinically infected hu-
mans, resulting, eventually, in reverse zoonosis (human to animal
transmission of a pathogen originated in animals). Such reverse
zoonosis has been reported so far in at least four dogs (two in
Hong Kong and two in the United States) (9), six cats (two in the
United States, and one each in Belgium, Hong Kong, France,
and Germany), farmed minks (in at least four farms in The
Netherlands) (10), and eight big felines in the Bronx Zoo in New
York (five tigers and three African lions). Considering the
number of infected people all over the world and the very few
cases reported in different animal species, it is thought that an-
imals play no or a negligible role in the epidemiology of
SARS-CoV-2. Just very recently, there has been speculation on
the possibility of a mink farm worker being exposed from an
infected animal (10), which might be the first potential docu-
mented zoonosis event within the pandemic.
The present case report aims to describe evidence in Spain of
SARS-CoV-2 infection in a 4-y-old domestic cat (European ×
Persian crossbreed). The owner of the animal died from COVID-19
(RT-PCR confirmed), and the animal was then taken by some
relatives who were also diagnosed with a mild-to-moderate form of
the disease, although SARS-CoV-2 infection was not confirmed at
the laboratory. The animal (C1) had another cat mate (C2) at home
that never showed any clinical sign.
Results
A relative of the deceased owner referred the cat (C1) to a
veterinary hospital due to severe dyspnoea. The clinical exami-
nation of the pet was performed with personal protective
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equipment (PPE) consisting of laboratory coat, face shield,
mask, and a double pair of gloves. The animal was normother-
mic, and blood analyses revealed mild anemia and severe
thrombocytopenia. Radiographically, a moderate bronchointer-
stitial pattern was observed bilaterally, but with more intensity in
craneoventral areas and right side of the lung. The proBNP
(Brain Natriuretic Peptide) test (IDEXX SNAP Feline proBNP
Test) resulted positive; this test measures the B-type natriuretic
peptide in blood, which is increased in response to excessive
stretching of heart muscle cells. In consequence, cardiac insuf-
ficiency was suspected, and feline hypertrophic cardiomyopathy
was subsequently diagnosed after echocardiography. Tests to
detect antigen against feline immunodeficiency virus and feline
leukemia virus resulted negative. The animal was kept at the
veterinary hospital overnight, but the course worsened during the
following afternoon, with lateral decubitus, shortness of breath,
agonic violent respiratory efforts, and apnoea. The current
owner, following the advice of the veterinary clinician, decided to
humanely euthanize the cat.
Due to the nature of the case, the necropsy was performed at
the biosafety level 3 facilities at the Centre de Recerca en Sanitat
Animal (Institut de Recerca i Tecnologia Agroalimentàries
[IRTA-CReSA]). For such necropsy, the PPE used consisted of
double overall, triple glove pairs, FFP3 mask, and a belt-
mounted powered air-purifying respirator. Externally, the ani-
mal had abundant fat resources, remnants of blood in the nostrils
and mouth, and evidence of tearing at the medial eye edges. At
necropsy, the most significant gross findings included moderate
to severe hypertrophy of the left ventricular and interventricular
wall with no cardiomegaly; lack of pulmonary collapse with
marked redness of lung lobes; 15 mL of thoracic serosangui-
neous fluid; liver paleness; presence of blood in mouth, trachea,
stomach, and intestines; and marked redness of the nasal turbi-
nates. Samples from lung, trachea, turbinates, lymph nodes
(mediastinal, submandibular, and mesenteric), tonsil, spleen,
bone marrow, heart (ventricles and atria), skeletal muscle, pan-
creas, stomach, small and large intestines, adrenal gland, parotid
gland, brain, and skin were taken and fixed by immersion in 10%
buffered formalin for subsequent histopathological and immu-
nohistochemistry studies. A second set of similar samples were
taken within Dulbecco’s modified Eagle’s medium to perform
SARS-CoV-2 real-time RT-PCR (11). In addition, nasal swabs,
rectal swabs, and lung swabs were taken for virological analyses.
The most significant histological features consisted of severe
pulmonary edema, congestion and hemorrhages, pulmonary
thrombosis of capillaries and small/medium-sized blood vessels,
nasal turbinate hemorrhages, interstitial fibrosis of left ventric-
ular and interventricular walls, mild hepatic lipidosis, splenic
hematopoiesis, mild membranoproliferative glomerulonephritis,
and focal nodular adrenal hyperplasia.
In addition, blood, plasma, and rectal and nasal swabs from C2
were obtained, and plasma from C1 taken by the veterinarian
the day before the euthanasia was also available. RT-qPCR and/
or antibody detection was also performed in these extra samples.
Results of RT-qPCR to detect three SARS-CoV-2 genes are
shown in Table 1. Viral genome was found in nasal swabs and
turbinates as well as mesenteric lymph node of C1, although with
high Ct values. The rest of the analyzed tissue results and C2
swabs were negative for the RT-qPCR methods. Immunohisto-
chemistry to detect SARS-CoV-2 antigen in formalin-fixed,
paraffin-embedded tissues also gave negative results.
The serum from both C1 and C2 yielded positive ELISA titers
of ≥1:4,000 for spike, S2, and receptor binding domain (RBD),
but was negative for N protein (Fig. 1). Also, both animals had
SARS-CoV-2 neutralizing antibodies (reciprocal dilution of the
half maximal inhibitory concentration, IC50, of 191 and 205 for
C1 and C2, respectively).
Viral genome could be partially obtained from the lymph node
sample of C1 (Global Initiative on Sharing Avian Influenza
Data, GISAID acc. EPI_ISL_482820) showing high identity
(99.997%) with the genomic sequence obtained from the initial
animal owner (GISAID acc. EPI_ISL_483059).
Discussion
Considering the clinical signs and both gross and microscopic
lesions, it was concluded that the cat developed cardiorespiratory
failure due to hypertrophic cardiomyopathy and secondary
thromboembolism. The severity of the condition during the visit
and the poor prognosis prompted the suggestion to euthanize the
animal. The detection of SARS-CoV-2 RNA in several samples
of C1, all of them with Ct values over 30 (low viral load), and
presence of antibodies (neutralizing and nonneutralizing) in both
C1 and C2, indicated both animals suffered from a productive
viral infection, probably linked to the exposure of the cats to
COVID-19−affected owners.
Experimental studies have demonstrated that cats are sus-
ceptible to SARS-CoV-2 infection and able to transmit it to di-
rect contact mates (4, 7). Those authors did not find clinical signs
in any of the inoculated cats. However, a certain degree of in-
terstitial pneumonia, and loss of cilia and epithelial necrosis and
inflammation in nasal turbinates and trachea, were observed in
one of these studies (7). Importantly, virus antigen was found in
epithelial cells of the nasal turbinates, necrotic debris in the
tonsil, submucosal glands of the trachea, and enterocytes of the
small intestine.
These experimental results, together with the few reports on
SARS-CoV-2 detection in domestic cats and wild felids, indicate
that felines are susceptible to infection by the novel coronavirus.
Moreover, the presence of lesions in the respiratory tract and
detection of viral antigen in both respiratory and digestive tracts
are compatible with the mild to moderate clinical course with
dyspnoea and diarrhea already seen in some of these naturally
exposed felines. Since the cat referred to in the present report
showed severe respiratory clinical signs and came from a
COVID-19 environment, a serious concern regarding the cause
of the signs was established. However, the clinical and patho-
logical diagnostic efforts indicated that the animal had significant
previous comorbidities such as feline hypertrophic cardiomyop-
athy (12) and severe thrombocytopenia. Therefore, the presence
of pulmonary edema, congestion and hemorrhage, and pulmo-
nary thrombosis and hydrothorax, all of them attributable to the
preexisting condition, accounted for the severity of the clinical
signs of the studied cat, and was the major reason to recommend
euthanasia. In fact, no evidence of viral pneumonia was found,
and no SARS-CoV-2 was retrieved from the lungs, findings that
have been observed in experimentally infected cats (7). The
detection of SARS-CoV-2 RNA in the mesenteric lymph node
may be explained by the tropism of the virus to the digestive tract
as well (7), since the virus seems to replicate in enterocytes, and
Table 1. Real-time RT-PCR testing for SARS-CoV-2
RT-qPCR detection
Animal ID Sample type UpE RdRp N
C1 Nasal swab (left) 33.69 34.01 35.11
C1 Nasal swab (right) 36.25 37.14 39.02
C1 Nose frontal 34.80 37.78 39.44
C1 Nose medial 33.70 34.90 BDL
C1 Nose caudal 39.05 BDL BDL
C1 Mesenteric lymph node 32.55 35.14 33.87
Results are expressed as Ct values of the RT-qPCR test (BDL, below the
detection limit, Ct > 40). UpE, upstream E gene; RdRp, RNA dependent-RNA
polymerase gene; N, nucleocapsid gene.














it would be feasible that remnants of virus or viral RNA may
reach the mesenteric lymph node by draining the small intestine. In
the cat of the present report, however, no lesions were observed in
the digestive tract. Therefore, no evidence of clinical signs or lesions
potentially caused by SARS-CoV-2 was attributed to C1. The sec-
ond animal (C2) never showed any clinical sign compatible to
SARS-CoV-2 infection, but this is not surprising, since such infec-
tion can remain completely asymptomatic (4).
To date, all described cases in cats have been related to
COVID-19−affected owners or other people that came into
contact with them. For the wild felids in New York, it has been
speculated that they were infected by an asymptomatic animal
caretaker or, alternatively, by one in a preclinical phase of the
COVID-19. This is also the situation of the present report’s cats.
Since the owner (who finally died because of the disease) and
several relatives suffered from COVID-19, it is very likely that
the pet was exposed, in a relatively continuous manner, to
SARS-CoV-2. Although the exact moment of exposure or in-
fection was not possible to determine based on the reconstruc-
tion of the chronological events around the present case (Fig. 2),
Fig. 1. Analysis of humoral response to SARS-CoV-2 in infected cats. The presence of anti−SARS-CoV-2 antibodies was evaluated in serum samples from two
SARS-CoV-2−infected (C1 and C2) and four uninfected (HC1, HC2, HC3, and HC4) cats. Corrected OD after background subtraction and serum dilution factor is shown
in y and x axes, respectively. Four SARS-CoV-2 antigens were evaluated: (A) whole spike, (B) spike S2-subunit, (C) spike RBD, and (D) nucleocapsid protein.
Fig. 2. Chronological events relating the clinical evolution of C1 in respect to the cat owners’ situation; besides the diagnosis of COVID-19 of the initial
owner, no SARS-CoV-2 testing was applied to relative 1 (R1), R2, and R3.
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the low amount of SARS-CoV-2 (Ct values of >32) found in
positive samples of C1, evidence of SARS-CoV-2 seroconver-
sion, the lack of compatible lesions with a viral disease, and the
preexisting morbid conditions suggest that SARS-CoV-2 infec-
tion in C1 was an incidental epidemiological finding. Therefore,
it was concluded that the cause of death of the studied cat was un-
related to the novel coronavirus. However, since the susceptibility of
domestic cats has now been established, extensive studies on domestic
cat SARS-CoV-2 prevalence are needed to precisely ascertain the
role of this sympatric species in the COVID19 pandemic. In addition,
although highly speculative at this stage, it would be important to
ascertain whether SARS-CoV-2 infection may be able to worsen al-
ready existing disorders in cats and other animal species.
Materials and Methods
Immunohistochemistry. A previously described immunohistochemistry tech-
nique to detect SARS-CoV-2 antigen (6), using the monoclonal antibody
40143-R019 (Sino Biological) at dilution 1:1,000, was applied on nasal tur-
binates, trachea, lung, mesenteric lymph nodes, and intestine.
In-House ELISA and Virus Neutralizing Tests. In-house ELISA techniques to
detect antibodies against SARS-CoV-2 spike, S2, and nucleocapsid protein (N)
as well as RBD were assayed on the plasma samples of C1 and C2. Briefly,
Nunc maxisorp ELISA plates were coated with 50 ng per well of Spike, S2,
RBD, or nucleocapsid protein (SinoBiologicals) in phosphate-buffered saline
(PBS) overnight at 4 °C. After washing with PBS + 0.05% of tween-20
(Sigma-Aldrich), plates were blocked using PBS/1% of bovine serum albu-
min (Miltenyi Biotech) for 2 h at room temperature. Four serial dilutions of
serum samples were added in duplicate starting at 1/500 dilution in blocking
buffer for 1 h at room temperature. To calculate the specific signal, the
background obtained using antigen-free wells was subtracted. Serum sam-
ples from four cats collected before 2019 were used as negative controls. All
samples were assayed in parallel in the same plate. The horseradish peroxidase-
conjugated Goat anti-Cat IgG (H+L) (1/20,000) (Jackson Immunoresearch) was
used as detection antibodies. Plates were revealed with o-Phenylenediamine
dihydrochloride (Sigma Aldrich) and stopped using 2 N of H2SO4. The signal
was analyzed as the optical density (OD) at 492 to 620.
A virus neutralization assay in plasma of both C1 and C2 was performed
following a previously published protocol (13).
SARS-CoV-2 Genome Sequencing. Viral RNA was extracted directly from C1
samples using the Indimag Pathogen kit (Indical Bioscience) and transcribed
to complementary DNA with the PrimeScript RT reagent Kit, using a com-
bination of oligo-dT and random hexamers, according to the manufacturer’s
protocol. For human nasopharyngeal swab samples, RNA was extracted us-
ing MagMAX Pathogen RNA/DNA Kit (ThermoFisher Scientific Inc.). DNA li-
brary preparation was performed using Swift amplicon SARS-CoV-2 panel
(Swift Biosciences). Sequencing-ready libraries where then loaded onto
Illumina MiSeq platform and a 300-base pair paired-end sequencing kit.
Sequence reads were quality filtered, and primer sequences were trimmed
off using cutadapt (14). Paired-end reads were matched using pear (15) and
mapped against coronavirus reference (NC_045512.2) using bowtie2 tool
(16). Consensus genomic sequence was called using samtools from the
resulting alignment at a 20× coverage for frontal nasal turbinate and mes-
enteric lymph node samples of C1 (GISAID accid EPI_ISL_482820) and human
sample (GISAID accid EPI_ISL_483059). Only genomic positions with at least
5× Q25 coverage were used. The nasal swab and other nasal turbinate
samples (medial and caudal) from C1 failed to provide sufficient data to
perform the analysis.
Data Availability. All study data are included in the article.
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